Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 7 de 7
1.
Pharmacopsychiatry ; 57(2): 78-81, 2024 Mar.
Article En | MEDLINE | ID: mdl-38471512

Antipsychotics can cause hematologic disorders, and they can have life-threatening consequences. Risperidone, less commonly associated with hematologic adverse effects, is an atypical antipsychotic medication used to treat conditions such as schizophrenia, bipolar disorder and irritability associated with autism. While risperidone primarily affects the central nervous system, it can have some hematologic adverse effects, although these are relatively rare. It is crucial to note that these side effects are not common, and most people taking risperidone do not experience hematologic disorders. The reporting of such disorders may be more frequent with clozapine compared to other atypical antipsychotics because clozapine treatment necessitates regular hematological monitoring 1.


Antipsychotic Agents , Clozapine , Humans , Risperidone/adverse effects , Clozapine/therapeutic use , Olanzapine , Benzodiazepines/adverse effects , Antipsychotic Agents/therapeutic use
2.
Appl Psychol Health Well Being ; 15(2): 686-704, 2023 05.
Article En | MEDLINE | ID: mdl-36178042

Reducing stigma among mental health and health professionals has been an ultimate priority in many countries worldwide. This study aimed to evaluate the effectiveness of a four-session educational intervention for reducing stigma of mental illness targeting family medicine trainees in Tunisia. A quasi-experimental design was adopted with an intervention group (N = 51) and a control group (N = 56). Pre-intervention data were collected using an online survey. A four-session seminar series was implemented and organized. Post-intervention data were collected immediately after the end of the intervention then 2 months thereafter. Instruments included Attribution Questionnaire (AQ-27), Self-Determination Scale (SDS), Empowerment Scale (ES), and Recovery Scale (RS). Repeated measures analysis of covariance and multiple analysis of covariance tests were carried out. Results revealed that the intervention had moderate effects on the AQ-27 score and on six of its stigma factors including factors of the dangerousness model. The intervention improved SDS score, but not ES or RS scores. Positive effects were observed immediately after the intervention and 2 months thereafter. Regular implementation of educational programs in clinical practice would be beneficial. Developing other anti-stigma methods is needed to address the concepts of recovery and responsibility of patients with mental illness.


Family Practice , Mental Disorders , Humans , Tunisia , Social Stigma , Mental Disorders/therapy , Mental Health
3.
Libyan J Med ; 17(1): 2095727, 2022 Dec.
Article En | MEDLINE | ID: mdl-35775812

Assertiveness is a constructive interpersonal behavior alternative to manipulation and aggression. Medical students (MSs) have daily interpersonal interactions with colleagues, patients and families. Yet, communication deficiencies due to hesitancy to speak-up assertively lead to adverse patient outcomes. This study aimed to assess levels of assertive behaviors (ABs), and to determine its predictors within a sample of first-year Tunisian MSs. This was a cross-sectional survey including 125 first-year MSs from Tunisia. ABs were measured by the Rathus assertiveness scale. Potential independent predictors of AB were evaluated using the following questionnaires: Rosenberg self-esteem scale, interpersonal communication skills inventory short-form-36quality of life questionnaire, and general health questionnaire. In addition, some MSs' characteristics were considered (eg; age, sex, living with family, assertiveness training, community work, personal medical field choice, smoking, and alcohol use). Univariate and multivariate analyses were performed. Among the 309 MSs, 125 (40.45%) responded to the survey. AB were found in 36.8% of MSs. Multiple linear regression models revealed that self-esteem global scores, sending clear messages, anxiety/depression and male sex were accountable for 31% in AB scores variance. Targeting self-esteem and interpersonal communication skills (sending clear messages) and identifying subgroups of students with anxiety/depression state would influence ABs.


Assertiveness , Students, Medical , Cross-Sectional Studies , Humans , Male , Self Concept , Surveys and Questionnaires
4.
J Ment Health ; 30(1): 36-42, 2021 Feb.
Article En | MEDLINE | ID: mdl-31066323

BACKGROUND: Temperamental dysregulation may constitute the link between predisposing genetic factors and affective disorders. AIMS: Evaluate affective temperaments in bipolar patients, healthy siblings and controls, and address the relationship between affective temperaments and recent life events in these groups. METHODS: Sixty bipolar patients, 60 patients' siblings and 60 controls were recruited. Assessment of life events in the last 6 months was performed using the Paykel's interview for recent life events. The Arabic version of Temperament Evaluation of Memphis, Pisa, Paris and San Diego - Auto-questionnaire was used to evaluate affective temperaments. RESULTS: Bipolar patients and siblings showed higher scores in cyclothymic and hyperthymic temperaments compared to controls. There were no significant differences in scores of irritable and anxious temperaments between the three groups.There was a strong relationship between anxious/cyclothymic temperaments and the high number of recent life events in bipolar patients and siblings. Contrary to bipolar patients and siblings, the number of recent life events in controls was not related to any dimension of affective temperament. CONCLUSIONS: Cyclothymic and hyperthymic temperaments were associated with bipolarity in patients and they could be characteristic traits of healthy siblings. Anxious/cyclothymic temperament might at least partially explain the high number of recent life events in bipolar patients and in siblings.


Bipolar Disorder , Temperament , Humans , Mood Disorders , Personality Inventory , Siblings , Surveys and Questionnaires
5.
J Clin Psychol ; 75(9): 1643-1657, 2019 09.
Article En | MEDLINE | ID: mdl-30995355

OBJECTIVE: We aimed to evaluate the links between different sleep parameters and suicidal ideation and behavior in remitted bipolar I patients. METHODS: One hundred eight remitted bipolar I patients were recruited from the psychiatry department of Razi Hospital. The third item of the "Hamilton Depression Rating Scale" was used to evaluate current suicidal behaviors. Circadian typology, daytime sleepiness and sleep quality were evaluated using the "Horne and Ostberg Morningness-Eveningness Questionnaire," the "Epworth Sleepiness Scale," and the "Pittsburgh Sleep Quality Index," respectively. RESULTS: Current suicidal ideation and behavior were significantly associated with circadian typology, daytime sleepiness, and sleep quality. After controlling for demographic variables (age and gender) and psychosocial factors (depression and substance use), suicidal ideation significantly contributed to sleep quality. Depression was a significant predictor within the second step when entered with other psychosocial variables; however, once suicide variables were included, depression was no longer a significant predictor. CONCLUSIONS: An evaluation of sleep's quality should be included in the suicide risk assessment of bipolar I patients.


Bipolar Disorder/epidemiology , Sleep Wake Disorders/epidemiology , Suicidal Ideation , Adult , Comorbidity , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Remission Induction , Tunisia/epidemiology
6.
Int J Clin Pharm ; 37(6): 992-5, 2015 Dec.
Article En | MEDLINE | ID: mdl-26373547

CASE PRESENTATION: Mr. S is a 32-year-old male with schizophrenia. Due to poor responses to various antipsychotic medications, he was started on clozapine with the dose titrated to 300 mg/day during a 4-week period. The weekly checks of the complete blood cell count showed gradual increases in the eosinophil count from normal values to 4320 per mm(3). Mr. S did not have any symptoms except some increased salivation. Clozapine was suspended, and eosinophils gradually began to decline to the normal range. Clozapine was subsequently re-started and there were no changes in eosinophil counts. Mr. S exhibited improvement of symptoms but complained of acute auricular pain and increased salivation, 8 weeks after clozapine rechallenge. He also developed a swelling of his both parotid glands. The diagnosis of clozapine-induced parotitis was suggested. Symptomatic medication was prescribed with a favorable outcome. CONCLUSION: We report a case of a patient who developed eosinophilia shortly after clozapine use, and then developed parotitis. There is debate in the literature over how to manage these complications of clozapine treatment. Generally they do not warrant clozapine discontinuation.


Antipsychotic Agents/adverse effects , Clozapine/adverse effects , Eosinophilia/chemically induced , Parotitis/chemically induced , Adult , Antipsychotic Agents/therapeutic use , Chlorpromazine/therapeutic use , Clozapine/therapeutic use , Humans , Leukocyte Count , Male , Schizophrenia/complications , Schizophrenia/drug therapy
7.
Epilepsy Res ; 108(7): 1168-73, 2014 Sep.
Article En | MEDLINE | ID: mdl-24970787

Glutathione-S-transferases enzymes are involved in the detoxification of several endogenous and exogenous substances. In this present study, we evaluated the effects of two glutathione-S-transferase polymorphisms, (GSTM1 and GSTT1) on epilepsy risk susceptibility in a Tunisian population. These polymorphisms were analyzed in 229 healthy subjects and 98 patients with epilepsy, using a polymerase chain reaction (PCR). Odds ratio (ORs) was used for analyzing results. The study results demonstrated that individuals with the GSTM1 null genotype were at an increased risk of developing epilepsy [OR=3.80, 95% confidence interval (CI) (2.15-4.78)], whereas no significant effects were observed between individuals with GSTT1 null genotype and epilepsy risk [OR=1.15, 95% CI (0.62-2.12)]. These genotyping finding revealed that the absence of GSTM1 activity could be contributor factor for the development of epilepsy disease.


Epilepsy/genetics , Genetic Predisposition to Disease/genetics , Glutathione Transferase/genetics , Polymorphism, Single Nucleotide/genetics , Adolescent , Adult , Aged , Aged, 80 and over , DNA Mutational Analysis , Female , Glutathione Transferase/metabolism , Humans , Male , Middle Aged , Odds Ratio , Tunisia/epidemiology , Young Adult
...